Loading...

Alumis Inc. Common Stock

ALMS•NASDAQ
Healthcare
Biotechnology
$25.08
$0.92(3.81%)
U.S. Market is Open • 15:25

Alumis Inc. Common Stock (ALMS) Stock Overview

Explore Alumis Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.1B
P/E Ratio-10.69
EPS (TTM)$-2.86
ROE-0.73%
Fundamental Analysis

AI Price Forecasts

1 Month$33.98
3 Months$50.34
1 Year Target$11.05

ALMS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alumis Inc. Common Stock (ALMS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.05.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.69 and a market capitalization of 3.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.48%
5-Day Change
8.51%
1-Month Change
-4.58%
3-Month Change
4.78%
6-Month Change
442.30%
Year-to-Date (YTD) Change
156.15%
1-Year Change
393.10%
3-Year Change
87.97%
5-Year Change
87.97%
All-Time (Max) Change
87.97%

Contact Information

https://www.alumis.com
(650) 231-6625
280 East Grand Avenue, South San Francisco, CA, 94080

Company Facts

168 Employees
IPO DateFeb 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions